Hypera company profile
Company profile
Hypera has 10,564 employees and is headquartered in São Paulo, Brazil.
Doril, Buscopan, Neosaldina and Engov are among the brands most people associate with Hypera S.A., a Brazilian drugmaker whose catalogue covers painkillers and anti-inflammatories, cold and flu remedies, antihistamines, digestive products, antiseptics such as Merthiolate, herbal medicines, vitamins, supplements and skincare lines. Its activities are concentrated in Brazil, and the group also sells generics under the neo quimica name as well as sweeteners under Adocyl and Zero-cal, with the Dramin and Cepacol brands rounding out its range.
In the fiscal year ended December 2025, revenue came to BRL 7.7 billion, up 3.4% from the prior year, and net income reached BRL 1.2 billion. Founded in 1999, the company has 10,564 employees and is headquartered in São Paulo.
Company facts
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Brazil
- Headquarters
- Av. Magalhães de Castro, 4800, 05676-120, São Paulo
- Employees
- 10,564
- Chief executive
- Breno Pires de Oliveira
- Founded
- 1999
- Fiscal year
- January - December
- Listing
- HYPE3 · B3
- Indices
- Ibovespa
- Currency
- BRL
- ISIN
- BRHYPEACNOR0
- Website
- hypera.com.br
Hypera and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| HyperaHYPE3 | Brazil | $2.58B | 10,564 | 28.1% | 8.09 |
| Genomma Lab InternacionalLAB/B | Mexico | $776.89M | 1,801 | 20.0% | 8.71 |
| AlmirallALM | Spain | $2.45B | 2,108 | 9.6% | 30.2 |
| Siegfried HoldingSFZN | Switzerland | $3.4B | 4,454 | 16.7% | 16.7 |
| Hims & Hers HealthHIMS | United States | $3.42B | 2,442 | -6.4% | — |
| FagronFAGR | Belgium | $1.97B | 4,880 | 14.3% | 19.5 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
